Science

Sarbajit Mukherjee: Excited to share my 50th publication from Roswell Park

Sarbajit Mukherjee/LinkedIn

Jan 16, 2025, 09:48

Sarbajit Mukherjee: Excited to share my 50th publication from Roswell Park

Sarbajit Mukherjee, Associate Professor and Co-Leader of GI Translational Research Group at Roswell Park shared a recent article by him and colleagues on X:

“Excited to share my 50th publication from Roswell Park.

This clinical trial represents years of hard work, and I’m so grateful to my mentor Dr. Renuka Iyer, Ipsen, NANETS and the patients and families who supported this journey.”

“Phase II Study of Nanoliposomal Irinotecan (Nal-IRI) with 5-Fluorouracil and Leucovorin in Refractory Advanced High-Grade Neuroendocrine Cancer of Gastroenteropancreatic (GEP) or Unknown Origin“

Authors: Sarbajit Mukherjee, Harsha Pattnaik, Sahithi Sonti, Mrinalini Ramesh, Prantesh Jain, Robert A. Ramirez, Christos Fountzilas, Deepak Vadehra, Kristopher Attwood and Renuka Iyer

Sarbajit Mukherjee

For more updates, follow OncoDaily.

5-Fluorouracil cancer clinical trial Harsha Pattnaik Ipsen Kristopher Attwood leucovorin Mrinalini Ramesh NANETS Nanoliposomal Irinotecan neuroendocrine cancer OncoDaily Oncology Renuka Iyer Roswell Park Sahithi Sonti Sarbajit Mukherjee

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage